On June 24, 2026, the Therapeutic Goods Administration (TGA) updated its guidance on the Personal Importation Scheme for prescription cancer drugs. For Australian patients dealing with advanced malignancies, the scheme offers a legal route to import specialized medicines that are either not registered in Australia or are experiencing local supply issues.

At Critical Kare Pharma, we are dedicated to helping patients navigate this pathway safely. Sourcing original medicines like Keytruda and Herceptin with end-to-end tracked logistics ensures Australian patients receive authentic therapies under strict safety controls.

Navigating the TGA Personal Importation Scheme

• Valid Prescription: Australian law requires a valid prescription from an Australian-registered medical practitioner.
• Quantity Limits: Patients are permitted to import up to a 3-month supply per shipment, with a maximum of a 15-month supply imported within a calendar year.
• Cold-Chain Validation: Due to Australia's geographic distance, shipments of biologics require high-performance thermal insulation and data logging to guarantee quality upon arrival.

Geographic isolation shouldn't limit treatment options. By providing complete documentation, certificate verification, and secure shipping to Sydney, Melbourne, Brisbane, and regional Australia, Critical Kare Pharma helps patients secure the treatments they need. We remain your dedicated partner in clinical logistics.